**Core Concept**
The question is testing the knowledge of intravenous anesthetics with bronchodilatory properties, which are crucial in managing patients with asthma or chronic obstructive pulmonary disease (COPD). **Propofol** and **Ketamine** are two commonly used anesthetics with bronchodilatory effects, but the question is specifically looking for a potent bronchodilator.

**Why the Correct Answer is Right**
The correct answer is **Ketamine**. Ketamine is a potent bronchodilator due to its ability to inhibit the release of histamine from mast cells, which contributes to bronchoconstriction. Additionally, ketamine has a direct relaxant effect on airway smooth muscles, leading to bronchodilation. This property makes ketamine an excellent choice for anesthetizing patients with asthma or COPD.

**Why Each Wrong Option is Incorrect**
**Option A:** Propofol is a sedative-hypnotic agent but does not have significant bronchodilatory effects.
**Option B:** Midazolam is a benzodiazepine with anxiolytic and sedative properties but lacks bronchodilatory effects.
**Option D:** Fentanyl is an opioid analgesic and does not have bronchodilatory properties.

**Clinical Pearl / High-Yield Fact**
In patients with asthma or COPD, ketamine can be used as a first-line agent for anesthesia induction due to its bronchodilatory effects and ability to maintain spontaneous respiration.

**Correct Answer: C. Ketamine**